NEW YORK (GenomeWeb) – Clinical genomic analysis and reporting firm Omicia announced it has acquired variant detection software maker Spiral Genetics for an undisclosed amount.

Seattle-based Spiral Genetics offers a graph-based technology for structural variant detection, population-scale data mining, population-specific reference genomes, and lossless data compression technologies. Its existing customers include clinical labs, biotech firms, and government-led sequencing programs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.